General MedicationsSUBCUTANEOUSGeneric
TAKHZYRO
lanadelumab-flyo
Standard Dose
Refer to label-specific dosage instructions.
Max Dose
See product label
Primary Use
Marketed solution containing LANADELUMAB.
Summary
Product profile Marketed solution containing LANADELUMAB.
Dose form and route SOLUTION · SUBCUTANEOUS
Structured Monograph
Clinical summary
Product profile Marketed solution containing LANADELUMAB. Dose form and route SOLUTION · SUBCUTANEOUS
Monitoring
- • Review the product-specific label before prescribing.
Interaction Notes
- • Interaction data should be confirmed against the corresponding label.